IBDEI0XU ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16706,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16706,1,4,0)
 ;;=4^205.12
 ;;^UTILITY(U,$J,358.3,16706,1,5,0)
 ;;=5^CML,In Relapse
 ;;^UTILITY(U,$J,358.3,16706,2)
 ;;=^336471
 ;;^UTILITY(U,$J,358.3,16707,0)
 ;;=284.81^^92^940^14
 ;;^UTILITY(U,$J,358.3,16707,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16707,1,4,0)
 ;;=4^284.81
 ;;^UTILITY(U,$J,358.3,16707,1,5,0)
 ;;=5^Aplastic Anemia d/t Drugs
 ;;^UTILITY(U,$J,358.3,16707,2)
 ;;=^335245
 ;;^UTILITY(U,$J,358.3,16708,0)
 ;;=284.89^^92^940^13
 ;;^UTILITY(U,$J,358.3,16708,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16708,1,4,0)
 ;;=4^284.89
 ;;^UTILITY(U,$J,358.3,16708,1,5,0)
 ;;=5^Aplastic Anemia d/t Chronic Disease
 ;;^UTILITY(U,$J,358.3,16708,2)
 ;;=^87880
 ;;^UTILITY(U,$J,358.3,16709,0)
 ;;=289.84^^92^940^119
 ;;^UTILITY(U,$J,358.3,16709,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16709,1,4,0)
 ;;=4^289.84
 ;;^UTILITY(U,$J,358.3,16709,1,5,0)
 ;;=5^Thrombocytopenia,Heparin Induced
 ;;^UTILITY(U,$J,358.3,16709,2)
 ;;=^336542
 ;;^UTILITY(U,$J,358.3,16710,0)
 ;;=V10.91^^92^940^67
 ;;^UTILITY(U,$J,358.3,16710,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16710,1,4,0)
 ;;=4^V10.91
 ;;^UTILITY(U,$J,358.3,16710,1,5,0)
 ;;=5^H/O Neuroendocrine CA Tumor
 ;;^UTILITY(U,$J,358.3,16710,2)
 ;;=^338494
 ;;^UTILITY(U,$J,358.3,16711,0)
 ;;=V10.91^^92^940^66
 ;;^UTILITY(U,$J,358.3,16711,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16711,1,4,0)
 ;;=4^V10.91
 ;;^UTILITY(U,$J,358.3,16711,1,5,0)
 ;;=5^H/O Malignant Neoplasm,Unspec
 ;;^UTILITY(U,$J,358.3,16711,2)
 ;;=^338494
 ;;^UTILITY(U,$J,358.3,16712,0)
 ;;=465.9^^92^941^70
 ;;^UTILITY(U,$J,358.3,16712,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16712,1,4,0)
 ;;=4^465.9
 ;;^UTILITY(U,$J,358.3,16712,1,5,0)
 ;;=5^URI
 ;;^UTILITY(U,$J,358.3,16712,2)
 ;;=URI^269878
 ;;^UTILITY(U,$J,358.3,16713,0)
 ;;=462.^^92^941^61
 ;;^UTILITY(U,$J,358.3,16713,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16713,1,4,0)
 ;;=4^462.
 ;;^UTILITY(U,$J,358.3,16713,1,5,0)
 ;;=5^Sore Throat
 ;;^UTILITY(U,$J,358.3,16713,2)
 ;;=^2653
 ;;^UTILITY(U,$J,358.3,16714,0)
 ;;=466.0^^92^941^3
 ;;^UTILITY(U,$J,358.3,16714,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16714,1,4,0)
 ;;=4^466.0
 ;;^UTILITY(U,$J,358.3,16714,1,5,0)
 ;;=5^Bronchitis,Acute
 ;;^UTILITY(U,$J,358.3,16714,2)
 ;;=^259084
 ;;^UTILITY(U,$J,358.3,16715,0)
 ;;=112.1^^92^941^79
 ;;^UTILITY(U,$J,358.3,16715,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16715,1,4,0)
 ;;=4^112.1
 ;;^UTILITY(U,$J,358.3,16715,1,5,0)
 ;;=5^Vulvovaginitis,Candidal
 ;;^UTILITY(U,$J,358.3,16715,2)
 ;;=^18615
 ;;^UTILITY(U,$J,358.3,16716,0)
 ;;=616.0^^92^941^13
 ;;^UTILITY(U,$J,358.3,16716,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16716,1,4,0)
 ;;=4^616.0
 ;;^UTILITY(U,$J,358.3,16716,1,5,0)
 ;;=5^Cervicitis
 ;;^UTILITY(U,$J,358.3,16716,2)
 ;;=^21925
 ;;^UTILITY(U,$J,358.3,16717,0)
 ;;=599.0^^92^941^71
 ;;^UTILITY(U,$J,358.3,16717,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16717,1,4,0)
 ;;=4^599.0
 ;;^UTILITY(U,$J,358.3,16717,1,5,0)
 ;;=5^UTI
 ;;^UTILITY(U,$J,358.3,16717,2)
 ;;=UTI^124436
 ;;^UTILITY(U,$J,358.3,16718,0)
 ;;=460.^^92^941^45
 ;;^UTILITY(U,$J,358.3,16718,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16718,1,4,0)
 ;;=4^460.
 ;;^UTILITY(U,$J,358.3,16718,1,5,0)
 ;;=5^Nasopharyngitis, Acute
 ;;^UTILITY(U,$J,358.3,16718,2)
 ;;=^26543
 ;;^UTILITY(U,$J,358.3,16719,0)
 ;;=372.30^^92^941^14
 ;;^UTILITY(U,$J,358.3,16719,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16719,1,4,0)
 ;;=4^372.30
 ;;^UTILITY(U,$J,358.3,16719,1,5,0)
 ;;=5^Conjunctivitis
 ;;^UTILITY(U,$J,358.3,16719,2)
 ;;=^27546
